Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation

by Alberts, M., Angiolillo, D.J, Bhatt, D.L, Deliargyris, E.N, Kimmelstiel, C., Mehran, R., Prats, J., Rosengart, T., Scheiman, J., Schneider, D.J, Steg, P.G
Published 2022

Cost-Consequence Analysis of Using Cangrelor in High Angiographic Risk Percutaneous Coronary Intervention Patients: A US Hospital Perspective

by Bhatt, D.L, Claussen, M., Cyr, P.L, Gibson, C.M, Jensen, I.S, Mahaffey, K.W, Prats, J., Salahuddin, K., Steg, P.G, Stone, G.W, Winkler, T., Wu, E.
Published 2022

Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Coronary Stenting: Insights From CHAMPION

by Bhatt, D.L, Deliargyris, E.N, Gibson, C.M, Hamm, C.W, Harrington, R.A, Leonardi, S., Lopes, R.D, Mahaffey, K.W, Peterson, B.E, Prats, J., Price, M.J, Steg, P.G, Stone, G.W, White, H.D
Published 2022

Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX

by Bhatt, D.L, Cavender, M.A, CHAMPION PHOENIX Investigators*, Deliargyris, E.N, Gibson, C.M, Hamm, C.W, Harrington, R.A, Leonardi, S., Lopes, R.D, Mahaffey, K.W, Prats, J., Price, M.J, Steg, P.G, Stone, G.W, White, H.D
Published 2022

Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI

by Ballantyne, C.M, Bhatt, D.L, Brinton, E.A, Budoff, M.J, Doyle, R.T., Jr, Gibson, C.M, Giugliano, R.P, Granowitz, C., Jacobson, T.A, Jiao, L., Juliano, R.A, Ketchum, S.B, Miller, M., Peterson, B.E, Pinto, D., Steg, P.G, Tardif, J.-C, Verma, S.
Published 2022

Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction

by Ballantyne, C.M, Bhatt, D.L, Brinton, E.A, Doyle, R.T., Jr, Gaba, P., Gibson, C.M, Giugliano, R.P, Granowitz, C., Jacobson, T.A, Jiao, L., Juliano, R.A, Ketchum, S.B, Martens, F.M.A.C, Miller, M., Steg, P.G, Tardif, J.-C, the REDUCE-IT Investigators
Published 2022

Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial

by Berwanger, O., Braunwald, E., Cikes, M., Claggett, B., De Pasquale, C.G, Fernandez, A., Filippatos, G., Granger, C.B, Jering, K., Køber, L., Landmesser, U., Lefkowitz, M., Lewis, E.F, Maggioni, A.P, Mann, D.L, McMurray, J.J.V, Menon, V., Merkely, B., Petrie, M.C, Petrov, I., Pfeffer, M.A, Rouleau, J.-L, Schou, M., Senni, M., Sim, D., Solomon, S.D, Steg, P.G, van der Meer, P., Wang, Y., Zhou, Y.
Published 2022

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

by Alings, M., Anand, S.S, Avezum, A., Bhatt, D.L, Bosch, J., Branch, K.R.H, Bruns, N.C, Commerford, P.J, COMPASS Investigators, Connolly, S.J, Dagenais, G.R, Dans, A.L, Diaz, R., Dyal, L., Eikelboom, J.W, Ertl, G., Felix, C., Fox, K.A.A, Guzik, T.J, Hart, R.G, Hori, M., Kakkar, A.K, Keltai, M., Kim, J.-H, Lanas, F., Leong, D., Lewis, B.S, Liang, Y., Lonn, E.M, Lopez-Jaramillo, P., Maggioni, A.P, Metsarinne, K.P, Moayyedi, P., Muehlhofer, E., O'Donnell, M., Parkhomenko, A.N, Piegas, L.S, Pogosova, N., Probstfield, J., Ryden, L., Shestakovska, O., Steg, P.G, Störk, S., Tonkin, A.M, Torp-Pedersen, C., Verhamme, P.B, Vinereanu, D., Widimsky, P., Yusoff, K., Yusuf, S., Zhu, J.
Published 2019

Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial

by Alings, M., Anand, S.S, Avezum, A., Bhatt, D.L, Bosch, J., Branch, K.R.H, Commerford, P.J, COMPASS Investigators, Connolly, S.J, Cook Bruns, N., Dagenais, G.R, Dans, A., Diaz, R., Dyal, L., Eikelboom, J.W, Ertl, G., Felix, C., Fox, K.A.A, Guzik, T., Hart, R.G, Hori, M., Kakkar, A., Keltai, M., Kim, J.-H, Lanas, F., Leong, D., Lewis, B.S, Liang, Y., Lonn, E.M, Lopez-Jaramillo, P., Maggioni, A.P, Metsarinne, K., Moayyedi, P., Muehlhofer, E., O'Donnell, M., Parkhomenko, A.N, Piegas, L.S, Pogosova, N., Probstfield, J., Ryden, L., Shestakovska, O., Steg, P.G, Störk, S., Tonkin, A.M, Torp-Pedersen, C., Verhamme, P.B, Vinereanu, D., Widimsky, P., Yusoff, K., Yusuf, S., Zhu, J.
Published 2019

Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial

by Aboyans, V., Alings, M., Anand, S.S, Avezum, A., Bhatt, D.L, Bosch, J., Branch, K.R.H, Bruns, N.C, Chen, E., Commerford, P.J, Connolly, S.J, Dagenais, G.R, Dans, A.L, Diaz, R., Eikelboom, J.W, Ertl, G., Felix, C., Fox, K.A.A, Guzik, T.J, Ha, J.-W, Hart, R.G, Hori, M., Kakkar, A., Keltai, K., Keltai, M., Kim, J.-H, Lamy, A., Lanas, F., Lanius, V., Leong, D.P, Lewis, B.S, Liang, Y., Liu, L., Lonn, E.M, Lopez-Jaramillo, P., Maggioni, A.P, Metsarinne, K.P, Misselwitz, F., Moayyedi, P., O'Donnell, M., Parkhomenko, A.N, Piegas, L.S, Pogosova, N., Probstfield, J.L, Ryden, L., Sharma, M., Steg, P.G, Störk, S., Tonkin, A.M, Torp-Pedersen, C., Varigos, J.D, Verhamme, P.B, Vinereanu, D., Widimsky, P., Yuan, F., Yusoff, K., Yusuf, S., Zhu, J.
Published 2017